Islay Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Islay Capital Management's ELV Position: Q2 2026 in Review
Islay Capital Management reduced its Elevance Health (ELV) stake by 98% in Q2 2026, selling an estimated $717K and leaving 40 shares worth $15.5K. The position accounts for 0.01% of the portfolio, ranked #167.
Islay Capital Management first reported a position in ELV in Q4 2019 and has held it in 26 quarters since. The position peaked at $867K in Q4 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Islay Capital Management held 40 shares of Elevance Health worth $15.5K as of Q2 2026.
- Islay Capital Management sold 1,933 Elevance Health shares in Q2 2026, an estimated $717K.
- Elevance Health made up 0.01% of Islay Capital Management's portfolio in Q2 2026, its #167 holding.
- Islay Capital Management first reported a position in Elevance Health in Q4 2019 and has held it in 26 quarters since.
- Islay Capital Management's Elevance Health position peaked at $867K in Q4 2025.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Islay Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.